Veronica P.
- Country
- Belgium
- Department
- Neurology
Research Overview
- Evaluation of Ocrelizumab Efficacy and Safety in Multiple Sclerosis Patients from a Prior Phase IIIb/IV Trial
- Evaluation of Efficacy, Safety, and Pharmacokinetics of Increased Ocrelizumab Dose in Adults with Relapsing Multiple Sclerosis: A Phase IIIb Randomized Controlled Trial
- Evaluation of Efficacy, Safety, and Pharmacokinetics of Increased Ocrelizumab Dose in Adults with Primary Progressive Multiple Sclerosis
Data & Insights
Has run more than one trial at 53 of 156 partner sites.
Specializations
Multiple Sclerosis Treatment
The investigator specializes in advancing therapeutic approaches for various forms of multiple sclerosis (MS), with particular emphasis on both relapsing and progressive forms of the disease.
- Relapsing Multiple Sclerosis (RMS) Management
- Primary Progressive Multiple Sclerosis (PPMS) Treatment
- Progressive MS Interventions
Their research encompasses innovative therapeutic strategies targeting different MS manifestations.
Novel Therapeutic Approaches
The investigator focuses on evaluating advanced treatment modalities, including monoclonal antibody therapies and metabolic interventions for MS management.
- Ocrelizumab Applications
- Obexelimab Development
- Metformin Add-on Therapy
Their work encompasses both established and experimental therapeutic approaches.
Disease Progression Research
The investigator studies disease modification strategies and disability progression markers in multiple sclerosis patients.
- Brain Remyelination Assessment
- Neurodegeneration Evaluation
- Disability Progression Monitoring
Their research includes evaluation of clinical outcomes and disease progression markers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.